Deerfield Management Company, L.P. (Series C) Haemonetics Corp Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.35 Billion
- Q2 2025
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Haemonetics Corp stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 3,529 shares of HAE stock, worth $173,838. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,529Holding current value
$173,838% of portfolio
0.01%Shares
2 transactions
Others Institutions Holding HAE
# of Institutions
336Shares Held
53.5MCall Options Held
540KPut Options Held
306K-
Black Rock Inc. New York, NY5.96MShares$294 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.95MShares$244 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.28MShares$211 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA2.15MShares$106 Million0.03% of portfolio
-
State Street Corp Boston, MA1.88MShares$92.8 Million0.01% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $2.53B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...